The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last year.
Who’s to blame? According to Friedman, Billings, Ramsey, the FDA. Why? Vioxx.
For details on extra scrutiny being applied by the FDA, see this CNNMoney summary.